In another recent investigation, Yang et al. demonstrated that the concomitant knockdown of glutamine synthase in the stroma and of glutaminase in cancer cells in a high-grade serous ovarian adenocarcinoma orthotopic mouse model disturbs the metabolic cross talk between cancer cells and CAFs. The gene discussed is GLUL; the disease is cancer.